Verwijs Marinus

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$689,536.07

Insider Activity of Verwijs Marinus

According to the SEC Form 4 filings, Verwijs Marinus, being in a position of

  1. CHIEF TECHNICAL OFFICER at Aerovate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23181 share for $599,571,
    over all time since 2022-11-02, has bought 0 shares, and sold 28300 shares for $689,536.

The largest sale of all time was on 2024-06-14 and amounted to 10600 shares of Aerovate Therapeutics, Inc. for $265,000.

Biography of Verwijs Marinus

No biography is available at this moment.

2024-06-14SaleAerovate Therapeutics, Inc.
AVTE
CHIEF TECHNICAL OFFICER
10,600
0.0413%
$25.00$265,000-91.71%
2024-05-02SaleAerovate Therapeutics, Inc.
AVTE
CHIEF TECHNICAL OFFICER
1,981
0.007%
$21.02$41,631-88.74%
2024-04-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF TECHNICAL OFFICER
5,300
0.0181%
$29.19$154,697-91.67%
2024-03-19SaleAerovate Therapeutics, Inc.
AVTE
CHIEF TECHNICAL OFFICER
5,300
0.0194%
$26.08$138,243-89.79%
2023-11-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF TECHNOLOGY OFFICER
970
0.0034%
$10.46$10,149+75.66%
2023-05-03SaleAerovate Therapeutics, Inc.
AVTE
SENIOR VICE PRESIDENT, CMC
759
0.003%
$20.79$15,779-21.11%
2022-11-02SaleAerovate Therapeutics, Inc.
AVTE
SENIOR VICE PRESIDENT, CMC
1,130
0.0046%
$18.89$21,346-3.93%
2022-11-02SaleAerovate Therapeutics, Inc.
AVTE
SENIOR VICE PRESIDENT, CMC
2,260
0.0092%
$18.89$42,691-3.93%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.